These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 1896245

  • 1. Mucosal antibodies to Haemophilus influenzae type b capsular polysaccharide.
    Gilsdorf JR, McDonnell WM.
    Pediatr Res; 1991 May; 29(5):420-3. PubMed ID: 1896245
    [Abstract] [Full Text] [Related]

  • 2. Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody.
    Lee YC, Kelly DF, Yu LM, Slack MP, Booy R, Heath PT, Siegrist CA, Moxon RE, Pollard AJ.
    Clin Infect Dis; 2008 Jan 15; 46(2):186-92. PubMed ID: 18171249
    [Abstract] [Full Text] [Related]

  • 3. Immunogenicity of Haemophilus b conjugate vaccine (meningococcal protein conjugate) in children with prior invasive Haemophilus influenzae type b disease.
    Walter EB, Moggio MV, Drucker RP, Wilfert CM.
    Pediatr Infect Dis J; 1990 Sep 15; 9(9):632-5. PubMed ID: 2235187
    [Abstract] [Full Text] [Related]

  • 4. Comparison of naturally acquired and vaccine-induced antibodies to Haemophilus influenzae type b capsular polysaccharide.
    Jelonek MT, Chang SJ, Chiu CY, Park MK, Nahm MH, Ward JI.
    Infect Immun; 1993 Dec 15; 61(12):5345-50. PubMed ID: 8225608
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. An enzyme-linked immunosorbent assay for quantitation of Haemophilus Influenzae type b polysaccharide-specific IgG1 and IgG2 in human and infant rhesus monkey sera.
    Dolan KT, Staub JM, Schofield TL, Ahonkhai VI, Ellis RW, Vella PP.
    J Immunoassay; 1991 Dec 15; 12(4):543-64. PubMed ID: 1806588
    [Abstract] [Full Text] [Related]

  • 7. Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate): immunogenicity and safety at various doses.
    Yogev R, Arditi M, Chadwick EG, Amer MD, Sroka PA.
    Pediatrics; 1990 Apr 15; 85(4 Pt 2):690-3. PubMed ID: 2107520
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Anti-capsular polysaccharide antibodies reduce nasopharyngeal colonization by Haemophilus influenzae type b in infant rats.
    Kauppi M, Saarinen L, Käyhty H.
    J Infect Dis; 1993 Feb 15; 167(2):365-71. PubMed ID: 8421170
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Age-dependent V region expression in the human antibody response to the Haemophilus influenzae type b polysaccharide.
    Lucas AH, Azmi FH, Mink CM, Granoff DM.
    J Immunol; 1993 Mar 01; 150(5):2056-61. PubMed ID: 8436834
    [Abstract] [Full Text] [Related]

  • 13. Disease caused by Haemophilus influenzae type b in the immediate period after homologous immunization: immunologic investigation.
    Sood SK, Daum RS.
    Pediatrics; 1990 Apr 01; 85(4 Pt 2):698-704. PubMed ID: 2107522
    [Abstract] [Full Text] [Related]

  • 14. Immunogenicity and reactogenicity of four Haemophilus influenzae type b capsular polysaccharide vaccines in Finnish 24-month-old children.
    Käyhty H, Peltola H, Eskola J.
    Pediatr Infect Dis J; 1988 Aug 01; 7(8):574-7. PubMed ID: 3050853
    [Abstract] [Full Text] [Related]

  • 15. In vitro induction of IgG1 and IgG2 secretion by B cells of children who developed invasive haemophilus disease despite vaccination.
    Chacko A, Granoff DM.
    Pediatr Res; 1991 Jul 01; 30(1):124-9. PubMed ID: 1891277
    [Abstract] [Full Text] [Related]

  • 16. Relation between enzyme-linked immunosorbent assay and radioimmunoassay for detection of antibodies to the capsular polysaccharide of Haemophilus influenzae type b.
    Kristensen K, Bentzon MW.
    APMIS; 1992 Feb 01; 100(2):142-6. PubMed ID: 1554488
    [Abstract] [Full Text] [Related]

  • 17. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
    Dashefsky B, Wald E, Guerra N, Byers C.
    Pediatrics; 1990 Apr 01; 85(4 Pt 2):682-9. PubMed ID: 2107519
    [Abstract] [Full Text] [Related]

  • 18. Clinical experience with Haemophilus influenzae type b conjugate vaccines.
    Mäkelä PH, Eskola J, Peltola H, Takala AK, Käyhty H.
    Pediatrics; 1990 Apr 01; 85(4 Pt 2):651-3. PubMed ID: 2179855
    [Abstract] [Full Text] [Related]

  • 19. Haemophilus influenzae type b immunization in infants in the United Kingdom: effects of diphtheria/tetanus/acellular pertussis/Hib combination vaccine, significant prematurity, and a fourth dose.
    Berrington JE, Cant AJ, Matthews JN, O'Keeffe M, Spickett GP, Fenton AC.
    Pediatrics; 2006 Apr 01; 117(4):e717-24. PubMed ID: 16549502
    [Abstract] [Full Text] [Related]

  • 20. Antibody response of Mexican infants to Haemophilus influenzae type b capsular polyribosylribitol phosphate. Differences between natural and vaccine induced (oligosaccharide-CRM197 conjugated vaccine) immunization.
    Massó F, Paéz A, Arista A, Salmón L, Montaño L.
    Arch Med Res; 1996 Apr 01; 27(4):539-45. PubMed ID: 8987192
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.